429 results on '"Jentzen, Walter"'
Search Results
2. Biodistribution and radiation dosimetry of 124I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models
3. Quantification performance of silicon photomultiplier-based PET for small 18F-, 68Ga- and 124I-avid lesions in the context of radionuclide therapy planning
4. First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
5. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
6. Positron range in combination with point-spread-function correction: an evaluation of different implementations for [124I]-PET imaging
7. [68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment
8. Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome
9. PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planning.
10. Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors.
11. PET imaging in thyroid cancer
12. Imaging of Differentiated Thyroid Cancer with Iodine-124 and F-18-FDG
13. Evaluation of [68Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
14. Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
15. Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
16. Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
17. Experimental consolidation and absolute measurement of the nat11C(p,x)nat11C nuclear activation cross section at 100 MeV for particle therapy physics
18. Biodistribution and radiation dosimetry of 124I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models.
19. Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy.
20. An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics
21. Preliminary results of the experimental cross sections of the long-lived β+ emitters of interest in PET range verification in proton therapy at clinical energies
22. Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial
23. Supplementary Figure from Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
24. Supplementary Data from Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
25. Efficacy and safety of124I-mIBG dosimetry-guided high activity131I-mIBG therapy of advanced pheochromocytoma or neuroblastoma
26. Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
27. Production of ¹¹C, ¹³N and ¹⁵O in proton-induced nuclear reactions up to 200 MeV
28. Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma.
29. Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging
30. Lesion Quantification Accuracy of Digital90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy
31. Digitale Positronenemissionstomografie – Entwicklung, Detektortechnologie und Perspektiven
32. 124I PET: Pretherapeutic Staging, Detection of Recurrent Thyroid Cancer and Dosimetry
33. Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study.
34. Quantitative performance of 124I PET/MR of neck lesions in thyroid cancer patients using 124I PET/CT as reference
35. Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
36. Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
37. Implementation of a Spatially-Variant and Tissue-Dependent Positron Range Correction for PET/CT Imaging
38. Comparison of the Safety and Tolerability of Paraaminohippurate (PAH) and Amino Acid (AA) Co-Infusion in Patients with Neuroendocrine Tumours Receiving Peptide Receptor Radionuclide Therapy (PRRT) : A Case Series of Eight Patients
39. [⁶⁸Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [¹⁷⁷Lu]Lu-PSMA-617 treatment
40. Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
41. Additional file 1 of Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
42. Positron range correction in combination with resolution recovery image reconstruction of [124I]-PET data
43. Intra-therapeutic dosimetry of [¹⁷⁷Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome
44. Multi-cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : results from the VISION trial sub-study
45. Additional file 1 of Positron range in combination with point-spread-function correction: an evaluation of different implementations for [124I]-PET imaging
46. First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
47. PET imaging in thyroid cancer
48. Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
49. Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
50. Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.